Dr. Carrie Michelle Hersh, DO

Dr. Hersh practices at Cleveland Clinic Lou Ruvo Center For Brain Health in Las Vegas, Nevada.

Dr. Hersh's NPI, 1942443072, was assigned on April 20, 2009. Dr. Hersh holds Ohio license 34.010803.

Dr. Hersh's primary practice is Cleveland Clinic Lou Ruvo Center for Brain Health, at 888 W Bonneville Ave, Las Vegas, NV 89106-0100. The practice phone is (702) 483-6000.

Dr. Hersh's primary practice is Cleveland Clinic Lou Ruvo Center For Brain Health in Las Vegas, Nevada. The medical group on file is Cleveland Clinic Lou Ruvo Center for Brain Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hersh practices. Vendor and product names are available with a free account.

Neurology is Dr. Hersh's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Hersh's licenses on file in 2 states: Ohio and Nevada.

CMS data shows 345 Medicare services from Dr. Hersh across 7 procedure codes in 2024, for 91 Medicare patients. Medicare paid $14,879 for them. Every service was in an office.

CMS counts 91 Medicare patients who saw Dr. Hersh in 2024. The largest group is 65 to 74, with 37 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hersh's median patient age at 49, with 76% women.

In 2024, Dr. Hersh wrote 431 Medicare Part D claims for 106 patients. 94% of them were for generic drugs. CMS names the drug for 283 of them, across 10 drugs with 11 or more claims each, at $131,413 in total drug cost. In 2023, CMS named 234 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Hersh for performance year 2024, reported as part of a group. Dr. Hersh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hersh as offering telehealth.

Dmand AI links 39 papers to Dr. Hersh, published from 2014 to 2025. 2020 was the busiest year, with 7. The most frequent topics are Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting and Immunologic Factors. Dr. Hersh has published most often in Mult Scler Relat Disord. Dr. Hersh's most frequent co-authors are Devon Scott Conway, MD, Jeffrey A. Cohen, MD and Le Hanh Hua, MD.

Dmand AI links Dr. Hersh to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Multiple Sclerosis, Relapsing-Remitting and Multiple Sclerosis.

CMS Open Payments shows 370 general payments to Dr. Hersh from 16 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 54% of the total. Biogen, Inc. paid the most, $86,777. It also lists 30 research payments totaling $36,753 from 2017 to 2024.